The Monocyte chemoattractant peptide protein 1 (MCP-1) has been described to attract circulating cells from blood vessels to the local injury sites and together with inflammatory mediators and ROS may contribute to the increased vascular injury39 and also cardiovascular disease in patients with CKD40. The gene discussed is CCL2; the disease is cardiovascular disorder.